PharmaCore? is a leader in fostering the commercial development of small molecule drug discovery and development
in pharmaceutical, discovery platform, and biotechnology companies.
The PharmaCore? offering parallels the drug discovery process and provides significant advantages at each step from lead discovery to lead optimization, chemical synthesis and scale-up of pharmaceutical intermediates as well as chemical process R&D.
PharmaCore? is an industry leader in custom organic synthesis using diverse chemistries to produce active pharmaceutical ingredients and scaffolds.
PharmaCore? has specialized GMP facilities for scale-up of pharmaceutical chemicals in multi-kilogram quantities. These include two GMP clean room synthesis laboratories. PharmaCore? assures the highest standards of quality management backed by an extensive GMP documentation system.
PharmaCore?'s novel, drug-like molecular building blocks have been developed to be chemically unique, providing discovery chemists with new directions to novel compounds. PharmaCore? continues to introduce new molecules, often unavailable elsewhere, that have broad application in medicinal and combinatorial chemistry.
PharmaCore? can provide medicinal chemistry services to support the needs of companies seeking to discover new small molecule pharmaceutical products.
United States
